Some of the matters that Mr. Manak has handled include:

Pentair Ltd. v. Xu Tongde Co.
Represent industrial companies in anti-counterfeiting and infringement matters in Asia.

Multilayer Stretch Cling Film Holdings v. AEP Industries, Inc.
USDC-WDTN Case: 2:12-cv-02195-JPM
Industrial film patent action.

Datascope Corp. v. Mindray Medical International Ltd.
Civil Action No. 11-CV-3488 (S.D.N.Y.)(VM)
Breach of medical device license agreement.

Zanfel Laboratories, Inc. v. The Rite Aid Corporation et al.
Civil Action No. 1:08-CV-0749 (W.D.MI)
Patent False Marking and False Advertising action.

Turtle Company Inc. v. The National Football League
Case No. 2:09-CV-03146-(D.MC)(MF)
Patent infringement action.

Human Genome Sciences, Inc. v. Advanced Life Science Institute, Inc.
Patent Interference 105,501 (RES)
Patent interference concerning DNA encoding S100 proteins.

Paz Systems, Inc. v. The Dakota Group Corp., et al.
Civil Action No.: 05-CV-4763 (E.D.N.Y.)
Trade secret case.

Abbott Laboratories v. Paddock and Par Pharmaceuticals
Hatch Waxman patent litigation.

Novo Nordisk v. Teva Pharmaceuticals USA, Inc.
Civil Action No. 02-332-SLR (D. Del.)
Patent infringement action and appeal of patent interference.

PE Corp. and Roche Molecular Systems v. MJ Research
Case No. 3-98-CV-1201 (D. Ct.)
Patent and antitrust litigation involving polymerase chain reaction and thermal cycler algorithms.

Leviton Manufacturing Co., Inc. v. Yatai USA, L.L.C., et al.
Several patent actions involving ground fault circuit interrupters.

University of Rochester v. Merck, Inc.
Patent Interference No. 104,289 (U.S.P.T.O. 2001)
Patent interference related to discovery of Cox-2 gene.

Merck Frosst Canada v. Monsanto Company
Case No. 1:99 CV 02620 (D. D.C.)
Patent action related to Cox-2 inhibitor VIOXX.

Monsanto Corp. and G.D. Searle & Co. v. Merck, Inc.
Large scale patent interference involving Cox-2 inhibitors.

Novo Nordisk A/S, et al v. Eli Lilly and Company and Genentech, Inc.
Civ. Action No. 97-4848 (AET) (D. N.J.)
Patent actions concerning recombinant DNA production of Human Growth Hormone

Eli Lilly and Company v. Novo Nordisk, A/S, et al.
Civ. Action No. IP 97-1834 C (S.D. In.)
Patent action involving drug formulation patent.

Genentech, Inc. v. Novo Nordisk, A/S and Biotechnology General
Civ. Action Nos. 95 Civ. 3474, 94 Civ. 8634, 95 Civ. 0110, 94 Civ. 1755
(S.D.N.Y.), and Intern. Trade Comm’n.
Multiple patent and antitrust actions concerning recombinant DNA production of Insulin and Human Growth Hormone.

Emory University v. Glaxo Wellcome, PLC
Civ. Action No. 1-96-CV 1868-GET (N.D.Ga.)
Patent action concerning AIDs drug Epivir.

Grumman Aerospace Corporation v. TechMatics, et al.
95 Civ. 966 (E.D.N.Y.)
Trade secret and unfair competition action.

Marion Merrell Dow, Inc., et al. v. IVAX Inc.
94 Civ. 1245 (S.D. Fla.)
Hatch-Waxman patent action.

Alpex Computer Corp. v. Nintendo Company, Ltd., et al.
86 Civ. 1749 (S.D.N.Y.)
Assisted Honorable Kimba M. Wood, U.S.D.J., and Special Master in trial relating to computer video game patent.

Hoechst Celanese Corporation v. Allied-Signal, Inc.
Civil Action No. 3:92CV66-MU (W.D.N.C.)
Patent and antitrust action relating to industrial fibers.

The Pretesting Company v. The Arbitron Company
93 Civ. 6031 S.D.N.Y.
Patent action concerning television audience survey algorithmic systems.

Wesley-Jessen Corporation v. Ciba Vision Corporation
Civil Action No. 90-SLR (D. Del.)
Patent and antitrust action concerning color contact lenses.

Baxter Healthcare Corporation, et al. v. Acufex Microsurgical, Inc.
Civil Action No. 88-408 JSL (N.D. Cal./D. Mass.)
Patent action concerning arthroscopic surgical equipment.

In re Nifedipine Capsule Patent Litigation (Pfizer Inc.)
MDL 774 M21-51 (JFK), Multi-district.
Hatch-Waxman patent actions concerning cardiovascular drug.

American Cyanamid Co. v. Ethicon, Inc.
Civil Action No. 85-3053 (D.N.J.)
Patent action concerning priority of surgical invention.

Procter & Gamble Co. v. Nabisco Brands, Inc. et al.
Civ. Action No. 84-333 LON
Trade secret and patent suit.

Transactions

Numerous joint biotech research, collaboration and commercialization transactions.

Represented underwriter in secondary public offering based on patent assets.

Represented international pharmaceutical company in bids to purchase drug and diagnostic business.

Sivensa S.A./FIOR
Represented Sivensa in trade secret, trademark, technology transfer and patent matters.

Engelhard Inc./Degussa Corporation and Degussa, AG.
Represented Degussa regarding sale and licensing of precious metals businesses.

Indian Pharma Cos.
Represented India drug companies in acquisitions of generic drug companies.

Ziff-Davis Interchange/Private Bidder
Represented European communication company in bid for MultiMedia software business.

IBM/Commodore International, Ltd.
Represented Commodore in negotiations concerning IBM hardware and software licenses relating to personal computers.